66 episodes

Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gastroenterology (FG). In 2019, Gut received its highest Impact Factor of 19.819, placing it third in the category of Gastroenterology and Hepatology. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

Gut podcas‪t‬ BMJ Group

    • Science
    • 4.3 • 3 Ratings

Gut is a leading international journal in gastroenterology and hepatology. It has an established reputation for publishing first class clinical research of the alimentary tract, the liver, biliary tree and pancreas. Gut delivers up-to-date, authoritative, clinically oriented coverage of all areas in gastroenterology. Regular features include articles by leading authorities, reports on the latest treatments for diseases, reviews and commentaries. Subscribers to Gut also receive Frontline Gastroenterology (FG). In 2019, Gut received its highest Impact Factor of 19.819, placing it third in the category of Gastroenterology and Hepatology. * The purpose of this podcast is to educate and to inform. The content of this podcast does not constitute medical advice and it is not intended to function as a substitute for a healthcare practitioner’s judgement, patient care or treatment. The views expressed by contributors are those of the speakers. BMJ does not endorse any views or recommendations discussed or expressed on this podcast. Listeners should also be aware that professionals in the field may have different opinions. By listening to this podcast, listeners agree not to use its content as the basis for their own medical treatment or for the medical treatment of others.

    Screening and eradication of Helicobacter pylori for gastric cancer prevention

    Screening and eradication of Helicobacter pylori for gastric cancer prevention

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Jyh-Ming Liou, Professor of Gastroenterology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan. The podcast is focussed on "Screening and eradication of Helicobacter pylori for gastric cancer prevention: the Taipei global consensus" published in paper copy in Gut in December 2020.
    Read the related article: https://gut.bmj.com/content/69/12/2093

    • 12 min
    European Registry on Helicobacter pylori management (Hp-EuReg)

    European Registry on Helicobacter pylori management (Hp-EuReg)

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Gisbert from the Gastroenterology Department, University Hospital of La Princesa, Madrid, Spain. The podcast is focused on "European Registry on Helicobacter pylori management (Hp-EuReg): patterns and trends in first-line empirical eradication prescription and outcomes of 5 years and 21 533 patients" published in paper copy in Gut in January 2021, and online, here: https://gut.bmj.com/content/70/1/40

    • 7 min
    Driving the efficacy of prebiotic intervention in obese patients

    Driving the efficacy of prebiotic intervention in obese patients

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital, UK, interviews Professor Delzenne, President of the Louvain Drug Research Institute, at the UCLouvain, Brussels, Belgium. The podcast is focused on "Discovery of the gut microbial signature driving the efficacy of prebiotic intervention in obese patients" published in paper copy in Gut in November 2020, and online at: https://gut.bmj.com/content/69/11/1975

    • 11 min
    Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes

    Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Rima Chakaroun who is a Clinician Scientist, Resident physician at the University Hospital in Leipzig, Germany, specialising in Endocrinology and Metabolic disease and a postdoctoral researcher and clinical investigator working on microbiome signatures in obesity in gut and beyond. The podcast is focused on "Adipose tissue derived bacteria are associated with inflammation in obesity and type 2 diabetes" published in paper copy in Gut in October 2020.
    https://gut.bmj.com/content/69/10/1796

    • 19 min
    Global burden of oesophageal and gastric cancer by histology and subsite in 2018

    Global burden of oesophageal and gastric cancer by histology and subsite in 2018

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Dr Melina Arnold from the Section of Cancer Surveillance, International Agency for Research on Cancer, Lyon, France. The podcast is focussed on "Global burden of oesophageal and gastric cancer by histology and subsite in 2018" published in paper copy in Gut in September 2020
    https://gut.bmj.com/content/69/9/1564

    • 8 min
    Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

    Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease

    Dr Philip Smith, Digital and Education Editor of Gut and Consultant Gastroenterologist at the Royal Liverpool Hospital interviews Professor Silvia Sookoian, who is Head of the Department of Clinical & Molecular Hepatology and Vice-Chair of Institute of Medical Research, at the Institute of Medical Research, Strategic Alliance between the National Scientific and Technical Research Council (CONICET)and the School of Medicine, University of Buenos Aires, Argentina; and Principal Investigator of the National Scientific and Technical Research Council. The podcast is focussed on "Intrahepatic bacterial metataxonomic signature in non-alcoholic fatty liver disease" published in paper copy in Gut in August 2020.
    Link to the article: https://gut.bmj.com/content/69/8/1483

    • 13 min

Customer Reviews

4.3 out of 5
3 Ratings

3 Ratings

Top Podcasts In Science

Listeners Also Subscribed To